www.camh.ca/en/science-and-research/science-and-research-staff-directory/stephenkish

Dr. Stephen Kish studies the human brain monoamine neurotransmitter systems in movement disorders with the objective to develop better treatment for ...

www.pharmtox.utoronto.ca/faculty-stephen-j-kish-phd

Stephen J. Kish, PhD. Professor, Psychiatry, Pharmacology Head, Human Neurochemical Pathology Laboratory Centre for Addiction and Mental Health.

www.researchgate.net/scientific-contributions/39799069_Stephen_J_Kish

Stephen J. Kish's 319 research works with 18787 citations and 1224 reads, including: Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex ...

onlinelibrary.wiley.com/doi/abs/10.1002/ana.410290119

Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. Dr Stephen J. Kish PhD. Corresponding ...

onlinelibrary.wiley.com/doi/full/10.1002/ana.410220318

We measured the rostrocaudal distribution of serotonin, dopamine, and their metabolites in Huntington's disease striatum (caudate and putamen). Mean levels ...

onlinelibrary.wiley.com/doi/abs/10.1111/j.1471-4159.1992.tb09439.x

Stephen J. Kish. Corresponding Author ... First published: August 1992. https://doi .org/10.1111/j.1471-4159.1992.tb09439.x. Cited by: 299. Read the full text.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2577569

Published online 2008 Apr 29. doi: 10.1016/j.neuropharm.2008.04.019 ... S. Frankel,* Mario E. Alburges,* Lloyd Bush,* Glen R. Hanson,* and Stephen J. Kish † ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC5101546

... Tina McCluskey,1,2,3,4 Alan A Wilson,2,3,6 and Stephen J Kish1,2,3,4,5,6,7 .... transporter (DAT), in the brains exposed to MA (see Kish, 2014 for a review).

www.ebenefitsgroup.com/AboutUs/OurTeam/StephenJRepkaII.aspx

Stephen J. Repka II. ... Darlene L. Kish · Stephen J. Repka II ... Stephen J. Repka II is co-founder and principal of eBenefits Group Northeast. He is also the ...